These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27634860)

  • 1. Treatment of T cell lymphoma in dogs.
    Moore AS
    Vet Rec; 2016 Sep; 179(11):277. PubMed ID: 27634860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric characterization and clinical outcome of CD4+ T-cell lymphoma in dogs: 67 cases.
    Avery PR; Burton J; Bromberek JL; Seelig DM; Elmslie R; Correa S; Ehrhart EJ; Morley PS; Avery AC
    J Vet Intern Med; 2014; 28(2):538-46. PubMed ID: 24495161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of canine non-indolent T cell lymphoma using the VELCAP-TSC protocol: A retrospective evaluation of 70 dogs (2003-2013).
    Goodman IH; Moore AS; Frimberger AE
    Vet J; 2016 May; 211():39-44. PubMed ID: 27017053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological characteristics and prognostic factors for canine multicentric non-indolent T-cell lymphoma: 107 cases.
    Purzycka K; Peters LM; Desmas I; Davies O; Chang YM; Lara-Garcia A
    Vet Comp Oncol; 2020 Dec; 18(4):656-663. PubMed ID: 32163214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
    Rebhun RB; Kent MS; Borrofka SA; Frazier S; Skorupski K; Rodriguez CO
    Vet Comp Oncol; 2011 Mar; 9(1):38-44. PubMed ID: 21303452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Apoptosis-regulating Proteins Bcl-2 and Bax in Lymph Node Aspirates from Dogs with Lymphoma.
    Meichner K; Fogle JE; English L; Suter SE
    J Vet Intern Med; 2016 May; 30(3):819-26. PubMed ID: 27013187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation.
    Aresu L; Martini V; Rossi F; Vignoli M; Sampaolo M; Aricò A; Laganga P; Pierini A; Frayssinet P; Mantovani R; Marconato L
    Vet Comp Oncol; 2015 Dec; 13(4):348-62. PubMed ID: 23782432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy.
    Blaxill J; Buzzacott P; Finlay J
    Vet Comp Oncol; 2022 Mar; 20(1):215-226. PubMed ID: 34464024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.
    Valli VE; Kass PH; San Myint M; Scott F
    Vet Pathol; 2013 Sep; 50(5):738-48. PubMed ID: 23444036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of canine nodal T-cell lymphomas classified as CD8+ or CD4-CD8- by flow cytometry.
    Harris LJ; Rout ED; Labadie JD; Avery PR; Fernandez M; Yoshimoto J; Avery AC
    Vet Comp Oncol; 2020 Sep; 18(3):416-427. PubMed ID: 31951040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatosplenic and hepatocytotropic T-cell lymphoma: two distinct types of T-cell lymphoma in dogs.
    Keller SM; Vernau W; Hodges J; Kass PH; Vilches-Moure JG; McElliot V; Moore PF
    Vet Pathol; 2013 Mar; 50(2):281-90. PubMed ID: 22711745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma.
    Brown PM; Tzannes S; Nguyen S; White J; Langova V
    Vet Comp Oncol; 2018 Mar; 16(1):108-113. PubMed ID: 28508557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine T-zone lymphoma: unique immunophenotypic features, outcome, and population characteristics.
    Seelig DM; Avery P; Webb T; Yoshimoto J; Bromberek J; Ehrhart EJ; Avery AC
    J Vet Intern Med; 2014; 28(3):878-86. PubMed ID: 24655022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of the updated Kiel classification in canine high-grade T-cell lymphomas.
    Jankowska U; Jagielski D; Czopowicz M; Sapierzyński R
    Vet Med Sci; 2024 Jul; 10(4):e1398. PubMed ID: 38767567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific immunotypes of canine T cell lymphoma are associated with different outcomes.
    Deravi N; Berke O; Woods JP; Bienzle D
    Vet Immunol Immunopathol; 2017 Sep; 191():5-13. PubMed ID: 28895866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of single-agent mitoxantrone as chemotherapy for relapsing canine lymphoma.
    Lucroy MD; Phillips BS; Kraegel SA; Simonson ER; Madewell BR
    J Vet Intern Med; 1998; 12(5):325-9. PubMed ID: 9773407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The animal-dependent risk factors in canine T-cell lymphomas.
    Jankowska U; Jagielski D; Czopowicz M; Sapierzyński R
    Vet Comp Oncol; 2017 Jun; 15(2):307-314. PubMed ID: 26300427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma delta T-cell large granular lymphocyte lymphoma in a dog.
    Ortiz AL; Carvalho S; Leo C; Riondato F; Archer J; Cian F
    Vet Clin Pathol; 2015 Sep; 44(3):442-7. PubMed ID: 25965815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine nodal marginal zone lymphoma: Descriptive insight into the biological behaviour.
    Cozzi M; Marconato L; Martini V; Aresu L; Riondato F; Rossi F; Stefanello D; Comazzi S
    Vet Comp Oncol; 2018 Jun; 16(2):246-252. PubMed ID: 29205839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response rate after administration of a single dose of doxorubicin in dogs with B-cell or T-cell lymphoma: 41 cases (2006-2008).
    Beaver LM; Strottner G; Klein MK
    J Am Vet Med Assoc; 2010 Nov; 237(9):1052-5. PubMed ID: 21034344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.